Nanoscale diagnostics, or nanodiagnostics, offer unprecedented sensitivity and specificity in detecting diseases at their earliest stages. Techniques such as quantum dots and nanoscale sensors can identify biomarkers in blood or tissue samples at very low concentrations, enabling early diagnosis and timely intervention. For example, nanotechnology-based assays can detect cancer markers at a stage when the disease is still highly treatable.
